Unilever
UL | NYSE
$62.18
+$0.37 (+0.59%)
Sep 21, 2026, 12:02 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 46.36B | 50.35B | 59.77B | 60.76B | 60.29B | 59.6B | 60.88B | 60.07B | 56.28B | 52.44B | 50.8B |
Cost of Revenue | n/a | n/a | n/a | n/a | 34.43B | 34.43B | 35.91B | 35.91B | 30.26B | 30.26B | 28.68B |
Gross Profit | 20.38B | 50.5B | 59.77B | 60.76B | 25.86B | 25.18B | 24.97B | 24.17B | 26.02B | 22.19B | 22.12B |
Operating Income | 9.42B | 9.49B | 8.77B | 9.4B | 10.19B | 9.76B | 11.77B | 10.76B | 8.78B | 8.7B | 8.06B |
Interest Income | 400.95M | 412.88M | 434.73M | 473.78M | 367.55M | 442M | 571M | 484M | 359M | 251M | 322M |
Pretax Income | 8.33B | 8.67B | 8.4B | 8.87B | 9.64B | 9.34B | 11.25B | 10.34B | 8.55B | 8.56B | 7.83B |
Net Income | 5.64B | 6.08B | 5.56B | 5.74B | 6.64B | 6.49B | 8.29B | 7.64B | 5.83B | 6.05B | 5.42B |
Selling & General & Admin | n/a | 57M | 93M | 71M | 15.22B | 15.23B | 14.51B | 14.48B | 11.73B | 11.71B | 11.88B |
Research & Development | n/a | n/a | n/a | n/a | 949M | 949M | 908M | 908M | 847M | 847M | 800M |
Other Expenses | 35.84B | 40.34B | 50.91B | 51.29B | -494M | -766M | -2.22B | -1.98B | 4.67B | 924M | 1.38B |
Operating Expenses | 35.84B | 40.4B | 51B | 51.36B | 15.67B | 15.42B | 13.2B | 13.41B | 17.24B | 13.48B | 14.06B |
Interest Expense | 1.03B | 841.54M | 646M | 662M | 393M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 8.55B | 8.55B | 7.82B | 7.82B | 6.87B | 6.87B | 7.09B |
Cost & Expenses | 36.94B | 40.86B | 51B | 51.36B | 50.1B | 49.85B | 49.11B | 49.32B | 47.5B | 43.74B | 42.74B |
Income Tax Expense | 2.59B | 2.47B | 2.23B | 2.5B | 2.36B | 2.2B | 2.31B | 2.07B | 2.11B | 1.94B | 1.9B |
Shares Outstanding (Basic) | 2.18B | 2.18B | 2.47B | 2.49B | 2.52B | 2.53B | 2.53B | 2.54B | 2.57B | 2.59B | 2.62B |
Shares Outstanding (Diluted) | 2.18B | 2.2B | 2.47B | 2.5B | 2.51B | 2.53B | 2.54B | 2.55B | 2.57B | 2.59B | 2.63B |
EPS (Basic) | 2.59 | 2.60 | 2.25 | 2.30 | 2.64 | 2.56 | 3.26 | 3 | 2.27 | 2.32 | 2.07 |
EPS (Diluted) | 2.58 | 2.59 | 2.24 | 2.29 | 2.63 | 2.56 | 3.26 | 2.99 | 2.26 | 2.32 | 2.06 |
EBITDA | 10.52B | 11.11B | 12.56B | 13.01B | 12B | 11.11B | 10.83B | 10.71B | 10.95B | 10.75B | 10.29B |
EBIT | 9.42B | 9.85B | 10.81B | 11.25B | 10.97B | 10.12B | 9.85B | 9.64B | 9.85B | 9.64B | 9.13B |
Depreciation & Amortization | 1.11B | 1.26B | 1.76B | 1.76B | 1.03B | 989M | 980M | 1.07B | 1.09B | 1.11B | 1.16B |
Add to Watchlist
Select watchlists to add or remove UL